Distance Healing in Wound Healing (study is currently recruiting patients)
http://www.clinicaltrials.gov/ct/show/NCT00067717?order=1
Distance Healing in Wound Healing
This study is currently recruiting patients.
Verified by National Center for Complementary and Alternative Medicine (NCCAM) May 2004
Purpose
This trial examines the impact of patients’ knowledge of an experienced distant healer's efforts to heal them on measures of wound healing, psychosocial functioning, and physiological symptoms after plastic surgery.
Condition | Intervention | Phase |
Breast Reconstruction Surgery
|
Behavior: Distance healing
Behavior: Prayer
|
Phase I
Phase II
|
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: Placebo Effects in Distance Healing of Wounds
Eligibility
Ages Eligible for Study: 34 Years - 64 Years, Genders Eligible for Study: Female
Accepts Healthy Volunteers
Criteria
Inclusion Criteria:
- Women undergoing major plastic surgery (> 2 hours in length)
- Health status is excellent with no systemic disease, no limitation on activity, no danger of death or disease of one body system, well-controlled underlying disease
Exclusion Criteria:
- Remove history of breast or other cancers
- History of radiation therapy to the abdomen or any radiation within the past three months
- Non-English speaking
- Unable or unwilling to fill out questionnaires
- Current smoker
- Morbid obesity
- Circulatory inadequacies (i.e., diabetes, hypovolemia)
- Nutritional deficits as evidenced by neutropenia (WBC <2500/ml) or hypoalbuminemia (albumin <3.3mmg/dl) / chart review
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00067717
California
Complementary Medicine Research Institute, San Francisco, California, 94115, United States; Recruiting
Marilyn J. Schlitz, PhD 707-775-3500
schlitz@noetic.org
Marilyn J. Schlitz, PhD, Principal Investigator
More Information
Study ID Numbers: R21AT1437; SchlitzMJ
Last Updated: December 8, 2005
Record first received: August 25, 2003
ClinicalTrials.gov Identifier:
NCT00067717
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2006-02-06